We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

New Biomarker Discovered for Myasthenia Gravis

News   Aug 30, 2019 | Original story from the University of Alberta

 
New Biomarker Discovered for Myasthenia Gravis

U of A researchers Zaeem Siddiqi (left) and Derrick Blackmore pinpointed 12 metabolic byproducts that only appear in people with myasthenia gravis -- a biological marker that will improve diagnosis and allow for personalized treatments for the rare autoimmune disease. Credit: Ryan O'Byrne

 
 
 

RELATED ARTICLES

New Markers for Triple Negative Breast Cancer

News

Two biomarkers – a 44-gene DNA Damage Response (DDIR) signature and stromal tumor-infiltrating lymphocytes (sTILs) – can serve as prognostic markers in people diagnosed with triple negative breast cancer, according to a new study.

READ MORE

An Engineered Probiotic Could Be a Novel Treatment Avenue for Inflammatory Bowel Disease

News

A research team has developed a living material approach that uses a strain of genetically engineered E.coli Nissle gut bacteria as a locally acting probiotic.

READ MORE

Bile Duct Biomarker? Protein May Help Predict Outcomes for Patients With Lethal Cancer

News

Researchers have discovered how a gene-repressing protein could help to predict survival outcomes in patients with a malignant form of bile duct cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE